References
Ashburn MA, Streisand JB. Oral Transmucosal Fentanyl. Help or hinderance? Drug Saf 1994; 11(5): 295–300
Transmucosal fentanyl approved in US. Scrip 1993 Oct 22; (1866): 25
Anesta Oralet “ease of use” addresses “unmet clinical need”. FDC Reports — The Pink Sheet 1994 Feb 28: T&G-9
Fine PG, Marcus M, De Boer AJ, et al. An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain. Pain 1991; 45: 149–53
Fine PG, Hague BI, Stanley TH. Oral transmucosal fentanyl citrate. A noninvasive drug delivery system. P&T 1992; 17: 195–200
Streisand JB, Varvel JR, Stanski DR, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991; 75: 223–29
Streisand JB, Rosenberg JA, Ashburn MA, et al. Oral transmucosal fentanyl citrate: repeated dose pharmacokinetics [abstract]. Anesthesiology 1993; 79: A369
Friesen RH, Lockhart CH. Oral transmucosal fentanyl citrate for preanesthetic medication of pediatric day surgery patients with and without droperidol as a prophylactic antiemetic. Anesthesiology 1992; 76: 46–51
Ashburn MA, Streisand JB, Tarver SD, et al. Oral transmucosal fentanyl citrate for premedication in paediatric outpatients. Can J Anaesth 1990: 37(8): 857–66
Lind GH, Marcus MA, Mears SL, et al. Oral transmucosal fentanyl citrate for analgesia and sedation in the emergency department. Ann Emerg Med 1991 Oct; 20: 1117–20
Ashburn MA, Lind GH, Gillie MH, et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of postoperative pain. Anesth Analg 1993; 76: 377–81
Rights and permissions
About this article
Cite this article
Oral transmucosal fentanyl — a dangerous lollipop or a step forward in drug delivery?. Drugs Ther. Perspect 5, 9–10 (1995). https://doi.org/10.2165/00042310-199505040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199505040-00003